These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28938651)

  • 1. Positive transcription elongation factor b (P-TEFb) is a therapeutic target in human multiple myeloma.
    Zhang Y; Zhou L; Leng Y; Dai Y; Orlowski RZ; Grant S
    Oncotarget; 2017 Aug; 8(35):59476-59491. PubMed ID: 28938651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
    Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
    J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
    Dow EC; Liu H; Rice AP
    J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription Elongation Factor P-TEFb Is Involved in IL-17F Signaling in Airway Smooth Muscle Cells.
    Nakajima M; Kawaguchi M; Matsuyama M; Ota K; Fujita J; Matsukura S; Huang SK; Morishima Y; Ishii Y; Satoh H; Sakamoto T; Hizawa N
    Int Arch Allergy Immunol; 2018; 176(2):83-90. PubMed ID: 29649811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis.
    Iankova I; Petersen RK; Annicotte JS; Chavey C; Hansen JB; Kratchmarova I; Sarruf D; Benkirane M; Kristiansen K; Fajas L
    Mol Endocrinol; 2006 Jul; 20(7):1494-505. PubMed ID: 16484339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P-TEFb regulation of transcription termination factor Xrn2 revealed by a chemical genetic screen for Cdk9 substrates.
    Sansó M; Levin RS; Lipp JJ; Wang VY; Greifenberg AK; Quezada EM; Ali A; Ghosh A; Larochelle S; Rana TM; Geyer M; Tong L; Shokat KM; Fisher RP
    Genes Dev; 2016 Jan; 30(1):117-31. PubMed ID: 26728557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
    Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
    Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of P-TEFb elongation complex activity by CDK9 acetylation.
    Fu J; Yoon HG; Qin J; Wong J
    Mol Cell Biol; 2007 Jul; 27(13):4641-51. PubMed ID: 17452463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-TEFb Kinase Activity Is Essential for Global Transcription, Resumption of Meiosis and Embryonic Genome Activation in Pig.
    Oqani RK; Lin T; Lee JE; Choi KM; Shin HY; Jin DI
    PLoS One; 2016; 11(3):e0152254. PubMed ID: 27011207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of multiple cyclin subunits of human P-TEFb.
    Peng J; Zhu Y; Milton JT; Price DH
    Genes Dev; 1998 Mar; 12(5):755-62. PubMed ID: 9499409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic activity of Cdk9 is required for nuclear co-localization of the Cdk9/cyclin T1 (P-TEFb) complex.
    Napolitano G; Majello B; Lania L
    J Cell Physiol; 2003 Oct; 197(1):1-7. PubMed ID: 12942536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.
    Paparidis NF; Durvale MC; Canduri F
    Mol Biosyst; 2017 Jan; 13(2):246-276. PubMed ID: 27833949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of P-TEFb disrupts global transcription, oocyte maturation, and embryo development in the mouse.
    Oqani RK; Lin T; Lee JE; Kim SY; Sa SJ; Woo JS; Jin DI
    Genesis; 2016 Sep; 54(9):470-82. PubMed ID: 27488304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-TEFb goes viral.
    Zaborowska J; Isa NF; Murphy S
    Inside Cell; 2016 Apr; 1(2):106-116. PubMed ID: 27398404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CDK9 for Anti-Cancer Therapeutics.
    Mandal R; Becker S; Strebhardt K
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34062779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic targeting of the P-TEFb complex as a therapeutic strategy for chronic myeloid leukemia.
    Qing Y; Wang X; Wang H; Hu P; Li H; Yu X; Zhu M; Wang Z; Zhu Y; Xu J; Guo Q; Hui H
    Cell Commun Signal; 2021 Aug; 19(1):83. PubMed ID: 34372855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells.
    Sung TL; Rice AP
    Retrovirology; 2006 Oct; 3():66. PubMed ID: 17014716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin-dependent kinase-9 in B-cell malignancies: pathogenic role and therapeutic implications.
    Dominguez EC; Roleder C; Ball B; Danilov AV
    Leuk Lymphoma; 2023 Dec; 64(12):1893-1904. PubMed ID: 37552126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.